Science Warehouse Wins Contract with Global Health Research Leader
Science Warehouse, one of the fastest growing companies in the UK e-business sector, has won a 3-year contract to deliver purchasing process efficiencies and substantial cost savings for the London School of Hygiene & Tropical Medicine by implementing its market-leading technology.
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health. Its mission is global; to work in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.
Dr David Hames, Chairman of Science Warehouse, said: “Science Warehouse is proud to have become the leading e-marketplace solution for top UK academic and research institutions, with an outstanding track record of delivering what we promise. We are delighted to welcome the London School of Hygiene & Tropical Medicine to the Science Warehouse community and look forward to working in partnership with them to deliver on our shared goals of supporting world-class research and efficient cost-effective procurement.”
Science Warehouse e-procurement solutions are chosen by leading organisations that want to improve procurement control and minimise cost but simultaneously deliver for their staff a highly intuitive “Amazon-like” user experience that fits naturally into their preferred way of working online. Science Warehouse solutions offer complete supplier reach, addressing both catalogue and non-catalogue spend, from the most complex research item to the most commonplace office item.
Keith Flanders, Head of Procurement at London School of Hygiene & Tropical Medicine, said: “The Science Warehouse e-marketplace portal has been used by major public research bodies as a tool to support research, and deliver savings across the academic community. The School is a world leader in its field, and this e-marketplace solution will support some of our key processes and help us to achieve increased efficiencies, in working towards our core goal of improving health and health equity in the UK and worldwide.”
The rapid growth of Science Warehouse, more than 30% in the last year alone, reflects the increasing recognition of the quality of our offering by buying organisations and their staff. Science Warehouse now hosts over 10 million products across all purchasing categories and connects more than 60,000 users with over 18,000 suppliers for electronic trading. In the UK public research sector, Science Warehouse solutions have been implemented by more than 22 of the UK’s leading universities, all seven of the UK’s Research Councils and a range of other leading research bodies.
Related News
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance